Lung Cancer Trial, Recruiting NCT06481813 Sponsor: Nantes University Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06481813
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients with lung cancer:

  • Adults who have been newly diagnosed with non-small cell lung cancer (NSCLC) or a related lung cancer type (CPC)
  • People who are receiving care at Nantes University Hospital
  • People who are covered by a social security or equivalent health insurance scheme
  • People receiving systemic treatment such as chemotherapy, immunotherapy, targeted therapy, or treatment as part of another clinical trial (only where that other trial is not blinded/secret about which treatment is given)
  • People who have agreed to take part by signing the study consent form

For healthy volunteers:

  • Adults covered by a social security or equivalent health insurance scheme
  • People with no known infectious illness, cancer history, chronic autoimmune disease, or current immune-suppressing treatment
  • People who have agreed to take part by signing the study consent form

For an additional sub-study (ancillary study):

  • People with advanced (metastatic) NSCLC that has a specific genetic change called KRAS G12C, who are being treated with Sotorasib, Adagrasib, or a similar KRAS G12C-targeting medicine, either alone or combined with another treatment

Who may not be able to join:

For patients with lung cancer:

  • People who have previously received anticancer treatment for lung cancer
  • People who have not agreed to participate in the BREATHE collection
  • People with a history of another cancer (not including thoracic/chest cancer) where there has been evidence of disease within the last 2 years
  • People currently enrolled in another clinical trial where the treatment is blinded (meaning it is unknown which treatment is being given)
  • People under legal guardianship
  • People receiving AME (French state medical aid) (confirm with trial site)
  • Women who are pregnant or breastfeeding

For healthy volunteers:

  • People under legal guardianship
  • People receiving AME (French state medical aid) (confirm with trial site)
  • Women who are pregnant or breastfeeding

For the ancillary sub-study:

  • Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02.40.16.59.30

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 December 2024
Est. completion
1 December 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov